+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Sirolimus Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027

  • ID: 4851200
  • Report
  • May 2019
  • Region: Global
  • 166 pages
  • Transparency Market Research
1 of 2

Global Sirolimus Market: Overview

The global sirolimus market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on application, distribution channel, and region.

A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises a competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region, thereby presenting a thorough analysis of the overall competitive scenario in the global sirolimus market.

Global Sirolimus Market: Key Segments

  • In terms of application, the global sirolimus market has been segmented into organ transplant rejection, lymphangioleiomyomatosis (LAM), and sirolimus coated balloons & catheter devices.
  • Based on distribution channel, the market has been classified into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment is anticipated to expand at a high CAGR during the forecast period.
  • The market has been analyzed based on price variations, technology trends, and presence of key players. The market size and forecast for each of these segments have been provided for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year. 

Global Sirolimus Market: Regional Outlook

  • In terms of region, the global sirolimus market has been segmented into North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East (South Africa, GCC Countries, and Rest of Middle East & Africa).
  • The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year. The research study also covers the competitive scenario in these regions. 

Companies Mentioned in Report

The report also profiles players in the market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Companies profiled in the global sirolimus market include Pfizer, Inc., Biocon, Dr. Reddy’s Laboratories Ltd., Concept Medical, Inc., Stentys SA, Torrent Pharmaceuticals Ltd., Zydus Cadila, and Intas Pharmaceuticals Ltd.

Note: Product cover images may vary from those shown
2 of 2
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Sirolimus Market

4. Market Overview
4.1. Introduction
4.1.1. Application Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Sirolimus Market Analysis and Forecast, 2016-2026

5. Market Outlook
5.1.Disease Prevalence & Incidence Rate globally with key countries
5.2.Pipeline Analysis
5.3.Supply Chain Analysis
5.4.Pricing Analysis by Product & Manufacturers
5.5.Global Sirolimus Market, by Consumption Volume (Kg) (2018)
5.6.Overview of Sirolimus Manufacturing Process

6. Global Sirolimus Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Application, 2016-2026
6.3.1. Organ Transplant Rejection
6.3.2. Lymphangioleiomyomatosis (LAM)
6.3.3. Sirolimus Coating Balloon & Catheter Devices
6.4. Market Attractiveness, by Application

7. Global Sirolimus Market Analysis and Forecast, by Distribution Channel
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Distribution Channel, 2016-2026
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Online Pharmacies
7.4. Market Attractiveness, by Distribution Channel

8. Global Sirolimus Market Analysis and Forecasts, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Country/Region

9. North America Sirolimus Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Application, 2016-2026
9.2.1. Organ Transplant Rejection
9.2.2. Lymphangioleiomyomatosis (LAM)
9.2.3. Sirolimus Coating Balloon & Catheter Devices
9.3. Market Value Forecast, by Distribution Channel, 2016-2026
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Online Pharmacies
9.4. Market Value Forecast, by Country, 2016-2026
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Application
9.5.2. By Distribution Channel
9.5.3. By Country

10. Europe Sirolimus Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Application, 2016-2026
10.2.1. Organ Transplant Rejection
10.2.2. Lymphangioleiomyomatosis (LAM)
10.2.3. Sirolimus Coating Balloon & Catheter Devices
10.3. Market Value Forecast, by Distribution Channel, 2016-2026
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Pharmacies
10.4. Market Value Forecast, by Country/Sub-region, 2016-2026
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Application
10.5.2. By Distribution Channel
10.5.3. By Country/Sub-region

11. Asia Pacific Sirolimus Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast, by Application, 2016-2026
11.2.1. Organ Transplant Rejection
11.2.2. Lymphangioleiomyomatosis (LAM)
11.2.3. Sirolimus Coating Balloon & Catheter Devices
11.3.Market Value Forecast, by Distribution Channel, 2016-2026
11.3.1. Hospital Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Online Pharmacies
11.4.Market Value Forecast, by Country/Sub-region, 2016-2026
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Application
11.5.2. By Distribution Channel
11.5.3. By Country/Sub-region

12. Latin America Sirolimus Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Application, 2016-2026
12.2.1. Organ Transplant Rejection
12.2.2. Lymphangioleiomyomatosis (LAM)
12.2.3. Sirolimus Coating Balloon & Catheter Devices
12.3. Market Value Forecast, by Distribution Channel, 2016-2026
12.3.1. Hospital Pharmacies
12.3.2. Retail Pharmacies
12.3.3. Online Pharmacies
12.4. Market Value Forecast, by Country/Sub-region, 2016-2026
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Application
12.5.2. By Distribution Channel
12.5.3. By Country/Sub-region

13. Middle East & Africa Sirolimus Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Application, 2016-2026
13.2.1. Organ Transplant Rejection
13.2.2. Lymphangioleiomyomatosis (LAM)
13.2.3. Sirolimus Coating Balloon & Catheter Devices
13.3. Market Value Forecast, by Distribution Channel, 2016-2026
13.3.1. Hospital Pharmacies
13.3.2. Retail Pharmacies
13.3.3. Online Pharmacies
13.4. Market Value Forecast, by Country/Sub-region, 2016-2026
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Israel
13.4.4. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Application
13.5.2. By Distribution Channel
13.5.3. By Country/Sub-region

14. Competition Landscape
14.1. Market Player - Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis, by Company (2018)
14.3. Company Profiles
14.3.1. Pfizer, Inc.
14.3.2. Biocon
14.3.3. Dr. Reddy’s Laboratories Ltd.
14.3.4. Concept Medical, Inc.
14.3.7. Stentys SA
14.3.8. Torrent Pharmaceuticals Ltd.
14.3.9. Zydus Cadila
14.3.10. Intas Pharmaceuticals Ltd.
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll